Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients

P E Hickman1, D A McGill, G Talaulikar

  • 1Department of Chemical Pathology, The Canberra Hospital and Department of Pathology, ANU Medical School, Canberra, Australian Capital Territory, Australia. peter.hickman@act.gov.au

Insights

In end-stage renal disease patients on dialysis, N-terminal pro-BNP (NT-pro-BNP) is a stronger predictor of mortality than troponin T (TnT) and troponin I (TnI). This finding aids in assessing cardiovascular risk in this vulnerable population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Cardiovascular mortality is high in end-stage renal disease (ESRD) patients.
  • Established cardiac biomarkers include troponin T (TnT), troponin I (TnI), B-type natriuretic peptide (BNP), and N-terminal pro-BNP (NT-pro-BNP).

Purpose of the Study:

  • To evaluate the prognostic significance of TnT, TnI, BNP, and NT-pro-BNP in ESRD patients.
  • To compare the predictive value of these cardiac biomarkers for all-cause mortality in dialysis patients.

Main Methods:

  • Prospective cohort study of 143 dialysis patients in Australia.
  • Collected clinical and biochemical data, including cardiac biomarkers.
  • Followed patients for a median of 30 months to record all-cause mortality.
  • Utilized Cox proportional hazards analysis to assess covariate-outcome relationships.

Main Results:

  • All tested cardiac markers (TnT, TnI, BNP, NT-pro-BNP) were associated with increased mortality in univariate analysis.
  • Multivariate Cox analysis identified only albumin and NT-pro-BNP as significant predictors of mortality.
  • NT-pro-BNP demonstrated a significant association with mortality (Hazard Ratio: 1.585, P = 0.004).

Conclusions:

  • N-terminal pro-BNP (NT-pro-BNP) offers superior prognostic information for mortality in ESRD patients on dialysis compared to TnT and TnI.
  • Albumin also showed prognostic value in this patient cohort.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...